Navigation Links
Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer

Case History Highlighted in AACR Cancer Journal

AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today the publication of data describing the dramatic clinical benefit of its lead product Advexin in a patient with a rare inherited form of cancer known as Li-Fraumeni Syndrome (LFS), a genetic disorder characterized by inherited mutations in the p53 tumor suppressor gene. This is the first reported treatment of Li-Fraumeni tumors with a therapy targeted to the underlying molecular cause of the disorder. These cancers are due to inherited abnormalities of p53 function which is directly addressed by ADVEXIN treatment. In addition, the results of the study evaluated biomarkers which confirmed the molecular mechanism of activity of ADVEXIN. These biomarkers will guide ADVEXIN therapy of other cancers with p53 abnormalities, which is one of the most common molecular defects found in virtually all types of cancer.

The patient was treated as part of a study at the Mary Crowley Medical Research Center in Dallas, TX and the importance of the findings were underscored by publication this week in the Spotlight on Clinical Response editorial highlights section of the current issue of Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

ADVEXIN treatment of a tumor in an LFS patient led to improvement of tumor-related symptoms and resulted in a complete response as determined by positron emission tomography (PET) scans. In addition, molecular biomarker studies using tumor biopsies before treatment detected abnormal levels of p53 protein predictive of ADVEXIN efficacy. Tumor biopsies analyzed after therapy identified restoration of p53 tumor suppressor function including suppression of tumor growth and induction of tumor cell death validating ADVEXIN's mechanisms of action.

"This case study showcases and provides p
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
2. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy

Post Your Comments:
(Date:11/20/2009)...irstCall/ -- Unilens Vision Inc. (OTC Bulletin Boa...ops, licenses, manufactures, distributes and marke...erating results for the first quarter ended Septem...oyalty income, were $1,683,673 in the FY2010 first...e previous year first quarter (FY2009). The decre...
(Date:11/20/2009)...e-FirstCall/ -- Landauer, Inc. ( LDR) , will ...arter and full year of 2009 pre-market on Tuesday,...onference call for investors on Tuesday, December ...access the live call by dialing 877-941-9205 (with...(international callers), or by visiting the "Inves...
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Blood Pressure Monitoring & Measurement In...//www.reportlinker.com/p0164309/Blood-Pressure-Mon...Analysis.html#utm_source=prnewswire&utm_medium...t of blood pressure is not only an indicator of ca...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Viles 26 Beckman LLC 3A Stop Your Headache NOT Your Liver 50688 1Viles 26 Beckman LLC 3A Stop Your Headache NOT Your Liver 50688 2Cancer Endangers Some Wildlife Species 50683 1Cancer Endangers Some Wildlife Species 50683 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3
...6 Results from RESTORE 2, a,placebo-controlled, P...al,compound retigabine significantly reduced the n...y partial-onset epilepsy when a 600 mg or 900 mg d...c drug (AED) therapy. Prior to,enrollment in the r...ing,seizures despite taking stable doses of up to ...
... Dec. 6 Researchers today report that after the i... erythropoiesis-stimulating agents (ESAs), a signi...nts who were on chemotherapy and who received ESAs... of blood per patient than those patients who rece...tations. The findings from this observational stu...
Other Medicine Technology:Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 2Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 3Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 4Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 5Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 2Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 3Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 4Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 5Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 6
(Date:11/23/2009)...cells in the brain is regulated by a peptide known...turation into nerve cells and is also important fo...in tissue, reveals new research from the Sahlgrens..., Although the research has been carried out usi... medicine for human beings, which could be given t...
(Date:11/23/2009)...-Science Focused Strategic Communications Agency H...on Professionals , Salem,...ife science-focused strategic communications agenc...arCom Gold Award in the design/website homepage ca...of Marketing and Communication Professionals. The ...
(Date:11/23/2009)...23/PRNewswire/--XiotechCorporationtodayannouncedth...(TM)7000storagesystem,poweredbyIntelligentStorageE...torageneeds,enablefuturegrowthanddeliversignifican...center. ,, MasonGeneral,locatedinShelton,Wash.,...e,s"MostWired-Rural"hospitalsin2008and2009foritssu...
(Date:11/23/2009)..., has understandably captured the attention of pub...wever, an analysis from Children,s Hospital Boston...nt (ED) during several recent flu seasons, shows t...V) -- takes a substantially greater disease toll a...though the data come from the pre-H1N1 influenza e...
(Date:11/23/2009)...longer to get sick, study finds , , MOND...that a genetic variation appears to play a major r... patients. , In fact, those with the variatio...die of complications of the disease. , "We,re... that make a person more or less susceptible to HI...
Breaking Medicine News(10 mins):Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3Health News:Genetic Variant Slows AIDS Progression 2
...INGTON, Dec. 2 Today Pascal Metrics Inc.,publicly...and risk management,services for hospitals and hea...l Metrics rapidly has become a worldwide leader fo...ke patients safer from,medical failure and errors....
...ER, Dec. 2 Barotz Dental is now one of only two d...r Assisted New Attachment,Procedure). This is the...d,and FDA approved for new attachment of gum and b...mizes pain and discomfort to the,patient, closes t...
...stmas Boxes Allow All to Celebrate With Traditiona... Angel Food Ministries ( www.angelfoodministries.c...quality food at low-costs, to anyone who wishes to...elebration. Host sites are now taking orders throu...
...ical Case Reviews Reveal Deficiencies in Care for ...c. 2 Members who recently sought expert medical ...eep uncertainty about their initial diagnosis or c...rs is a unique health benefit that calls upon top ...
...y Published Call to Action Highlights Need to Redu...ase Educational Efforts , , BETHESDA, Md., De...eases, (NFID) S.T.O.P. (Share. Teach. Outreach. ...prove adolescent meningococcal vaccination rates a...
...ls of tasimelteon show it could aid shift workers,...ec. 2 (HealthDay News) -- The experimental drug ta... jet lag or night shifts, according to the results...melteon, or a placebo. They were monitored for sev...
Other Medicine News:Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Angel Food Ministries to Distribute Holiday Grocery Relief 2Health News:Consumers Uncertain About Their Medical Diagnosis & Treatment 2Health News:Consumers Uncertain About Their Medical Diagnosis & Treatment 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:Drug Effective for Temporary Sleep Disruptions 2
...a compact RFID printing solution that can encode s...er/encoder is one of the most versatile in the ind...dia such as wristbands and smart labels, the R2844...er processing speed and more connectivity choices-...
HealthTrax Asset Tracking Software
...designed to protect a wandering resident from leav...ured. Such residents typically have been diagnosed... a head injury., At-risk residents wear a small W...nd points of exit are discreetly secured by WatchM...
PDC Smart™ Label
Medicine Products: